Actilax

Main information

  • Trade name:
  • Actilax 66% w/v Syrup
  • Dosage:
  • 66% w/v
  • Pharmaceutical form:
  • Syrup
  • Units in package:
  • Bottle, Amber PVC with white HDPE cap, LDPE wad and LDPE tamper evident ring, 500mL,
  • Class:
  • General sale
  • Prescription type:
  • General sale
  • Medicine domain:
  • Humans
  • Medicine type:
  • Allopathic drug
  • Manufactured by:
  • Lacsa Pty Ltd

Documents

Localization

  • Available in:
  • Actilax 66% w/v Syrup
    New Zealand
  • Language:
  • English

Therapeutic information

  • Therapeutic indications:
  • Treatment of acute, and prevention and treatment of Portal-Systemic Encephalopathy (PSE), including the stages of hepatic precoma and coma.

Other information

Status

  • Source:
  • Medsafe - Medicines Safety Authority - New Zealand
  • Authorization number:
  • 13008
  • Authorization date:
  • 24-10-2006
  • Last update:
  • 27-09-2017

11-6-2018

Exforge HCT (Novartis Europharm Limited)

Exforge HCT (Novartis Europharm Limited)

Exforge HCT (Active substance: amlodipine besylate / valsartan / hydrochlorothiazide) - Centralised - Transfer Marketing Authorisation Holder - Commission Decision (2018)3752 of Mon, 11 Jun 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/1068/T/66

Europe -DG Health and Food Safety